Terms ending in 2034
Every in-force patent on Eyepoint, Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,980,911 | Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents In force · High confidence | Eyepoint, Inc. | In force | High confidence | |
| US 10,220,048 | Compositions and Methods for Treating Ocular Diseases In force · Medium confidence | Eyepoint, Inc. | In force | Medium confidence | |
| US 12,152,023 | Compositions, Formulations and Methods for Treating Ocular Diseases In force · Medium confidence | Eyepoint, Inc. | In force | Medium confidence | |
| US 9,440,963 | Compositions, formulations and methods for treating ocular diseases In force · Medium confidence | Eyepoint, Inc. | In force | Medium confidence | |
| US 9,603,801 | Bioerodible Silicon-Based Compositions for Delivery of Therapeutic Agents In force · High confidence | Eyepoint, Inc. | In force | High confidence | |
| US D851,755 | Ocular Inserter In force · High confidence | Eyepoint Pharmaceuticals US, Inc. | In force | High confidence |
6 of 6 patents shown. Soonest term end first, then patent number.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.